Strong vaccine-induced CD8 T-cell responses have cytolytic function in a chimpanzee clearing HCV infection

PLoS ONE

Volumn 9, Issue 4, 2014, Pages

  Verstrepen, Babs E ^a   Verschoor, Ernst J ^a   Fagrouch, Zahra C ^a   Mooij, Petra ^a   De Groot, Natasja G ^a   Bontrop, Ronald E ^a   Bogers, Willy M ^a   Heeney, Jonathan L ^b   Koopman, Gerrit ^a  

^a BIOMEDICAL PRIMATE RESEARCH CENTRE   (Netherlands)

^b UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALANYLALANYLTHREONYLLEUCYLGLYCYLPHENYLALANYLGLYCYLALANYLTYROSINE; ALANYLTHREONYLLEUCYLGLYCYLPHENYLALANYLGLYCYLALANYLTYROSYLMETHIONINE; HEPATITIS VACCINE; ISOLEUCYLARGINYLTHREONYLGLYCYLVALYLARGINYLTHREONYLISOLEUCYLTHREONYLTHREONYLGLYCYLGLYCYLPROPYLISOLEUCYLPROLINE; LEUCYLGLYCYLPHENYLALANYLGLYCYLALANYLTYROSYLMETHIONYLSEYLLYSINE; LYSYLGLYCYLGLYCYLLEUCYLARGINYLPROPYLARGINYLALANYLGLYCINE; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; NONSTRUCTURAL PROTEIN 3; POLYPEPTIDE; THREONYLLEUCYLGLYCYLPHENYLALANYLGLYCYLALANYLTYROSYLMETHIONYLSERINE; UNCLASSIFIED DRUG; CORE PROTEIN; CYTOKINE; EPITOPE; HLA ANTIGEN CLASS 1; NS3 PROTEIN, HEPATITIS C VIRUS; VIRUS PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BINDING AFFINITY; CD8+ T LYMPHOCYTE; CHIMPANZEE; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOLYSIS; EPITOPE MAPPING; GENOTYPE; HEPATITIS C; LYMPHOCYTE FUNCTION; NONHUMAN; PROTEIN BINDING; RETROSPECTIVE STUDY; VIRAL CLEARANCE; AMINO ACID SEQUENCE; ANIMAL; BIOSYNTHESIS; CELLULAR IMMUNITY; CHEMISTRY; CYTOTOXICITY; DRUG EFFECTS; GENE EXPRESSION; GENETICS; HEPACIVIRUS; HUMORAL IMMUNITY; IMMUNIZATION; IMMUNOLOGY; MOLECULAR GENETICS; PAN TROGLODYTES; VIROLOGY;

AMINO ACID SEQUENCE; ANIMALS; CD8-POSITIVE T-LYMPHOCYTES; CYTOKINES; CYTOTOXICITY, IMMUNOLOGIC; EPITOPES; GENE EXPRESSION; HEPACIVIRUS; HEPATITIS C; HISTOCOMPATIBILITY ANTIGENS CLASS I; IMMUNITY, CELLULAR; IMMUNITY, HUMORAL; IMMUNIZATION; MOLECULAR SEQUENCE DATA; PAN TROGLODYTES; VIRAL CORE PROTEINS; VIRAL HEPATITIS VACCINES; VIRAL NONSTRUCTURAL PROTEINS;

EID: 84899743038     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0095103     Document Type: Article

References (29)

1. Bettauer RH (2010) Chimpanzees in hepatitis C virus research: 1998-2007. J Med Primatol 39: 9-23.
2. Bukh J (2012) Animal models for the study of hepatitis C virus infection and related liver disease. Gastroenterology 142: 1279-1287.
3. Bacchetti P, Deeks SG, McCune JM (2011) Breaking free of sample size dogma to perform innovative translational research. Sci Transl Med 3: 24-87.
4. Thimme R, Bukh J, Spangenberg HC, Wieland S, Pemberton J, et al. (2002) Viral and immunological determinants of hepatitis C virus clearance, persistence, and disease. Proc Natl Acad Sci U S A 99: 15661-15668. (Pubitemid 35403988)
5. Diepolder HM, Gruener NH, Heeney J (2003) Of chimps and men-finding the path to an HCV vaccine. Hepatology 37: 1472-1474. (Pubitemid 36667329)
6. Cooper S, Erickson AL, Adams EJ, Kansopon J, Weiner AJ, et al. (1999) Analysis of a successful immune response against hepatitis C virus. Immunity 10: 439-449. (Pubitemid 29205480)
7. Watanabe H, Wells F, Major ME (2010) Clearance of hepatitis C in chimpanzees is associated with intrahepatic T-cell perforin expression during the late acute phase. J Viral Hepat 17: 245-253.
8. Osburn WO, Fisher BE, Dowd KA, Urban G, Liu L, et al. (2010) Spontaneous control of primary hepatitis C virus infection and immunity against persistent reinfection. Gastroenterology 138: 315-324.
9. Prince AM, Brotman B, Lee DH, Pfahler W, Tricoche N, et al. (2005) Protection against chronic hepatitis C virus infection after rechallenge with homologous, but not heterologous, genotypes in a chimpanzee model. J Infect Dis 192: 1701- 1709. (Pubitemid 41587819)
10. Nascimbeni M, Mizukoshi E, Bosmann M, Major ME, Mihalik K, et al. (2003) Kinetics of CD4+ and CD8+ memory T-cell responses during hepatitis C virus rechallenge of previously recovered chimpanzees. J Virol 77: 4781-4793. (Pubitemid 36402828)
11. Rollier CS, Paranhos-Baccala G, Verschoor EJ, Verstrepen BE, Drexhage JA, et al. (2007) Vaccine-induced early control of hepatitis C virus infection in chimpanzees fails to impact on hepatic PD-1 and chronicity. Hepatology 45: 602-613. (Pubitemid 46450611)
12. Haaijman JJ, Heeney JL (1995) European centralized chimpanzee facility preclinical studies for evaluation of effective vaccines and therapeutic strtegies for AIDS. AIDS research at EC level. IOS press. pp. 139-148.
13. Hoffmeister B, Kiecker F, Tesfa L, Volk HD, Picker LJ, et al. (2003) Mapping T cell epitopes by flow cytometry. Methods 29: 270-281. (Pubitemid 36513443)
14. de Groot NG, Otting N, Arguello R, Watkins DI, Doxiadis GG, et al. (2000) Major histocompatibility complex class I diversity in a West African chimpanzee population: implications for HIV research. Immunogenetics 51: 398-409. (Pubitemid 30265030)
15. de Groot NG, Heijmans CM, Zoet YM, de Ru AH, Verreck FA, et al. (2010) AIDS-protective HLA-B*27/B*57 and chimpanzee MHC class I molecules target analogous conserved areas of HIV-1/SIVcpz. Proc Natl Acad Sci U S A 107: 15175-15180.
16. Balla-Jhagjhoorsingh SS, Koopman G, Mooij P, Haaksma TG, Teeuwsen VJ, et al. (1999) Conserved CTL epitopes shared between HIV-infected human long-term survivors and chimpanzees. J Immunol 162: 2308-2314. (Pubitemid 29288855)
17. Hoof I, Peters B, Sidney J, Pedersen LE, Sette A, et al. (2009) NetMHCpan, a method for MHC class I binding prediction beyond humans. Immunogenetics 61: 1-13.
18. Allen TM, Mothe BR, Sidney J, Jing P, Dzuris JL, et al. (2001) CD8(+) lymphocytes from simian immunodeficiency virus-infected rhesus macaques recognize 14 different epitopes bound by the major histocompatibility complex class I molecule mamu-A*01: implications for vaccine design and testing. J Virol 75: 738-749. (Pubitemid 32037277)
19. Loffredo JT, Sidney J, Wojewoda C, Dodds E, Reynolds MR, et al. (2004) Identification of seventeen new simian immunodeficiency virus-derived CD8+ T cell epitopes restricted by the high frequency molecule, Mamu-A*02, and potential escape from CTL recognition. J Immunol 173: 5064-5076. (Pubitemid 39387789)
20. Sette A, Vitiello A, Reherman B, Fowler P, Nayersina R, et al. (1994) The relationship between class I binding affinity and immunogenicity of potential cytotoxic T cell epitopes. J Immunol 153: 5586-5592. (Pubitemid 24377694)
21. Sidney J, Peters B, Moore C, Pencille TJ, Ngo S, et al. (2007) Characterization of the peptide-binding specificity of the chimpanzee class I alleles A 0301 and A 0401 using a combinatorial peptide library. Immunogenetics 59: 745-751. (Pubitemid 47415567)
22. Paul S, Weiskopf D, Angelo MA, Sidney J, Peters B, et al. (2013) HLA class I alleles are associated with peptide-binding repertoires of different size, affinity, and immunogenicity. J Immunol 191: 5831-5839.
23. Bell MJ, Burrows JM, Brennan R, Miles JJ, Tellam J, et al. (2009) The peptide length specificity of some HLA class I alleles is very broad and includes peptides of up to 25 amino acids in length. Mol Immunol 46: 1911-1917.
24. Fattori E, Zampaglione I, Arcuri M, Meola A, Ercole BB, et al. (2006) Efficient immunization of rhesus macaques with an HCV candidate vaccine by heterologous priming-boosting with novel adenoviral vectors based on different serotypes. Gene Ther 13: 1088-1096.
25. Zubkova I, Choi YH, Chang E, Pirollo K, Uren T, et al. (2009) T-cell vaccines that elicit effective immune responses against HCV in chimpanzees may create greater immune pressure for viral mutation. Vaccine 27: 2594-2602.
26. Shin EC, Capone S, Cortese R, Colloca S, Nicosia A, et al. (2008) The kinetics of hepatitis C virus-specific CD8 T-cell responses in the blood mirror those in the liver in acute hepatitis C virus infection. J Virol 82: 9782-9788.
27. Ramalingam RK, Meyer-Olson D, Shoukry NH, Bowen DG, Walker CM, et al. (2008) Kinetic analysis by real-time PCR of hepatitis C virus (HCV)-specific T cells in peripheral blood and liver after challenge with HCV. Journal of virology 82: 10487-10492. (Pubitemid 352691162)
28. Kim AY, Kuntzen T, Timm J, Nolan BE, Baca MA, et al. (2011) Spontaneous control of HCV is associated with expression of HLA-B 57 and preservation of targeted epitopes. Gastroenterology 140: 686-696.
29. Neumann-Haefelin C, Timm J, Schmidt J, Kersting N, Fitzmaurice K, et al. (2010) Protective effect of human leukocyte antigen B27 in hepatitis C virus infection requires the presence of a genotype-specific immunodominant CD8+ T-cell epitope. Hepatology 51: 54-62.